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Orlando, Florida, United States of America, 3 The Center for Infectious Disease Research and Vaccinology, Department of Veterinary and Biomedical Sciences, South
Dakota State University, Brookings, South Dakota, United States of America

Abstract
Vibrio cholerae produces cholera toxin (CT), an AB5 protein toxin that is primarily responsible for the profuse watery diarrhea
of cholera. CT is secreted into the extracellular milieu, but the toxin attacks its Gsa target within the cytosol of a host cell.
Thus, CT must cross a cellular membrane barrier in order to function. This event only occurs after the toxin travels by
retrograde vesicular transport from the cell surface to the endoplasmic reticulum (ER). The catalytic A1 polypeptide then
dissociates from the rest of the toxin and assumes an unfolded conformation that facilitates its transfer to the cytosol by a
process involving the quality control system of ER-associated degradation. Productive intoxication is blocked by alterations
to the vesicular transport of CT and/or the ER-to-cytosol translocation of CTA1. Various plant compounds have been
reported to inhibit the cytopathic activity of CT, so in this work we evaluated the potential anti-CT properties of grape
extract. Two grape extracts currently sold as nutritional supplements inhibited CT and Escherichia coli heat-labile toxin
activity against cultured cells and intestinal loops. CT intoxication was blocked even when the extracts were added an hour
after the initial toxin exposure. A specific subset of host-toxin interactions involving both the catalytic CTA1 subunit and the
cell-binding CTB pentamer were affected. The extracts blocked toxin binding to the cell surface, prevented unfolding of the
isolated CTA1 subunit, inhibited CTA1 translocation to the cytosol, and disrupted the catalytic activity of CTA1. Grape
extract could thus potentially serve as a novel therapeutic to prevent or possibly treat cholera.
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but the lack of lysine residues in the CTA1 polypeptide allows the
translocated toxin to avoid ubiquitination and subsequent
degradation by the 26S proteasome [17,22,23]. Instead, cytosolic
CTA1 regains an active conformation and attacks its Gsa target.
Disruptions to the CT trafficking/translocation itinerary will
block CTA1 passage into the cytosol and thereby generate a toxinresistant phenotype. Neutralizing antibodies will prevent CT
binding to the cell surface and, thus, productive intoxication [24].
Dissolution of lipid rafts with filipin or methyl b-cyclodextrin
prevents toxin endocytosis and/or transport to the Golgi
apparatus [5,6,25]. Endosome-to-Golgi and Golgi-to-ER transport
steps are inhibited by the expression of dominant negative ARF1
or Sar1 proteins [26,27]. Brefeldin A (BfA) blocks toxin transport
to the ER [8–10,26]. The loss of ERdj3 [28] or BiP [29] function
will prevent CTA1 translocation to the cytosol, as will ERAD
dysfunction [20]. An inhibition of CTA1 unfolding resulting from
treatment with 4-phenylbutyric acid, 10% glycerol, or mildly
acidic pH will also prevent the ER-to-cytosol export of CTA1
[15,16,18]. Although these studies have helped map the intracellular route of CT intoxication, they have only identified a few valid
options for therapeutic development. Ongoing efforts continue to
search for therapeutic agents that could be effective against
cholera and, preferably, other toxin-mediated diseases as well.

Introduction
Cholera toxin (CT), produced by Vibrio cholerae, is an AB5 toxin
responsible for the profuse, life-threatening diarrhea of cholera [1–
3]. This physiological response results from ADP-ribosylation of
Gsa by the catalytic A1 subunit of CT (CTA1). To reach its Gsa
target, CT travels from the cell surface to the endoplasmic
reticulum (ER) as an intact AB5 holotoxin [4]. CT initially
interacts with the target cell through binding of its B homopentamer to GM1 gangliosides in the host plasma membrane.
Surface-bound CT is then internalized into the host cell through
an endocytic mechanism involving lipid rafts [5,6]. The majority
of endocytosed toxin is degraded in the lysosomes, but the
functional pool of toxin is instead delivered to the trans-Golgi
network en route to the ER [7–10]. Reduction of the CTA1/
CTA2 disulfide bond occurs in the ER [11,12], which is then
followed by the separation of CTA1 from CTA2/CTB5 by protein
disulfide isomerase (PDI) [13,14]. Dissociation of the CTA1
subunit leads to its spontaneous unfolding and subsequent
recognition by the quality control system of ER-associated
degradation (ERAD) [15–18]. Misfolded or misassembled proteins
are recognized by ERAD, exported from the ER to the cytosol,
and degraded by the cytosolic ubiquitin-proteasome system [19].
CTA1 exploits ERAD for its ER-to-cytosol translocation [20,21],
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Figure 1. Grape extracts inhibit cholera intoxication of culture cells. (A–B) CHO cells were incubated for 2 h (A) or 18 h (B) with various
concentrations of CT in the absence or presence of grape extract before cAMP levels were quantified. (C) CHO cells were incubated for 2 h with
various concentrations of CT in the absence or presence of a chemically defined phenolic cocktail before cAMP levels were quantified. (D) CHO cells
were incubated for 2 h with 100 mM forskolin in the absence or presence of grape seed extract, grape pomace extract, or phenolic cocktail before
cAMP levels were quantified. For all panels, data are presented as percentages of the maximal cAMP response for the experiment (i.e., the cAMP level
obtained from untreated cells exposed to 100 ng/mL of CT or to 100 mM forskolin). The averages 6 standard deviations of 3–4 independent
experiments with triplicate samples are shown. In panels A–C, all experimental conditions were significantly different from the No Treatment control
at every matched toxin concentration (1-way ANOVA, p,0.05).
doi:10.1371/journal.pone.0073390.g001

We recently screened a select panel of plant compounds for
inhibitory activity against Shiga toxin (ST), another AB-type ERtranslocating toxin [30]. Plant compounds were screened because
polyphenols and other plant compounds have been shown to
inhibit CT intoxication and the release of ST from Escherichia coli
O157:H7 [31–34]. Grape seed extract and grape pomace (i.e.,
skin) extract each conferred substantial cellular resistance to ST
when applied simultaneously with the toxin to cultured Vero cells
[30]. Both extracts are Generally Recognized as Safe by the
United States Food and Drug Administration and are sold as
nutritional supplements under the names MegaNatural Gold
PLOS ONE | www.plosone.org

(grape seed extract) and MegaNatural GSKE (grape pomace
extract). In this work, we report the extracts inhibited CT activity
against cultured cells and intestinal loops. Application of the
extracts up to an hour after toxin exposure still generated a toxinresistant phenotype in cultured cells. Toxin resistance resulted
from extract-induced disruptions to multiple steps of the intoxication process, including CTB binding to the cell surface, CTA1
unfolding in the ER, CTA1 translocation to the cytosol, and
CTA1 ADP-ribosylation activity. Toxin trafficking to the ER,
CTA1/CTA2 redox status, and CTA1 separation from the
holotoxin were not affected by the extracts. These observations
2
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Table 1. Composition of the chemically defined phenolic
cocktail.

Compound
Caftaric acid
Catechin
Catechin gallate
Cyanidin
Delphinidin
Epicatechin
Epicatechin gallate
Epigallocatechin gallate
Gallic Acid
Kaempferol
Kuromanin
Malvin chloride
Oenin chloride
Peonidin
Petunidin
Protocatechin
Quercitrin
Resveratrol
Eighteen phenolic compounds commonly found in grape extract [37–40] were
mixed in Ham’s F-12 medium. The toxicity assay of Figure 1C used a final
working concentration of 5 mg/mL for each listed compound.
doi:10.1371/journal.pone.0073390.t001

indicate the grape extracts block specific events in the cell biology
of CT intoxication and suggest a new anti-toxin therapeutic use for
two existing nutritional supplements.

Materials and Methods
Ethics Statement
Intestinal loop experiments were performed with approval from
the South Dakota State University Institutional Animal Care and
Use committee, protocol number 11-008A. Animals were tranquilized and anesthetized with 6 mg/kg of Telazol and maintained
on isoflurane gas anesthesia, with oxygen by mask from an
anesthetic machine for the entire experimental period. The
experiment was terminated with euthanasia done in accordance
with the recommendations of the American Veterinary Medical
Association.

Figure 2. Grape extracts inhibit the diarrheatic response to CT
and LT. A ligated intestinal loop assay in neonatal pigs was used to
monitor net fluid accumulation in response to an 8 h challenge with CT
(A) or LT (B). Loops were injected with PBS alone or PBS containing
10 mg grape seed extract, 1 mg grape pomace extract, and/or 10 mg
toxin as indicated. Data represent the averages 6 standard deviations
of 3–4 replicate loops in a single pig for each toxin/experiment.
Statistically significant differences between loops challenged with toxin
in the absence vs. presence of either grape extract were detected for
both CT (p,0.001) and LT (p,0.01) by ANOVA. No significant
differences were noted between (i) loops treated with PBS alone and
any extract-treated loop; (ii) loops treated with seed extract and loops
treated with both seed extract and toxin; or (iii) loops treated with
pomace extract and loops treated with both pomace extract and toxin.
doi:10.1371/journal.pone.0073390.g002

Statistics
As indicated, data are presented as averages 6 standard
deviations or means 6 standard errors of the means. Data were
analyzed by one-way ANOVA using StatPlus from AnalystSoft,
Inc. (Vancouver, BC). A p value of ,0.05 was considered
statistically significant.

Sigma-Aldrich (St. Louis, MO). Cholesterol and phospholipids
were purchased from Avanti Polar Lipids (Alabaster, AL). Purified
phenolic compounds were purchased from ChromaDex, Inc.
(Irvine, CA). Grape seed and grape pomace extracts, provided by
Polyphenolics, Inc. (Madera, CA), were used at 100 mg/mL
concentrations for all experiments. Previous work has demonstrated the extracts are non-toxic to cultured cells at concentrations up to 500 mg/mL [30].

Materials
Digitonin was purchased from Calbiochem (La Jolla, CA). CT
and the E. coli heat-labile toxin (LT) were purchased from List
Biologicals (Campbell, CA). The anti-KDEL antibody was
purchased from Stressgen (San Diego, CA). The CTA1/CTA2
heterodimer, CTB pentamer, fluorescein isothiocyanate-conjugated CTB pentamer (FITC-CTB), GM1, BfA, thermolysin, acasein, PDI, and anti-CTA1 antibody were purchased from
PLOS ONE | www.plosone.org
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Figure 3. Grape extracts inhibit toxin binding to the cell surface. CHO cells were placed on ice and exposed to FITC-CTB for 30–60 min. The
cells were washed with PBS to remove unbound toxin, and fluorescent output was determined with a plate reader. (A) Cells were co-incubated with
FITC-CTB and grape seed or pomace extract for 60 min. (B) Cells were exposed to grape extract for 30 min. The extracts were removed by washing
with PBS, and the cells were then exposed to FITC-CTB for 30 min. (C) Cells were exposed to FITC-CTB for 30 min. Unbound toxin was removed by
washing with PBS, and the cells were then exposed to grape extract for 30 min. (D) A mixture of FITC-CTB and grape extract was placed in a
3500 MWCO dialysis cup. After an overnight dialysis, FITC-CTB was applied to cells for 60 min. All steps of all experiments were performed at 4uC, and
all experiments contained a No Treatment control in which FITC-CTB was not exposed to grape extract but was otherwise treated identically to the
extract-treated samples. For all panels, data are presented as percentages of the maximal FITC-CTB signal obtained from the No Treatment control.
The means 6 standard errors of the means of 4 independent experiments with 6 replicates per condition are shown. Asterisks denote statistically
significant differences between untreated and extract-treated cells (1-way ANOVA, p,0.01).
doi:10.1371/journal.pone.0073390.g003

Cell Culture Toxicity Assays

Intestinal Loop Assay

CHO-K1 cells (ATCC #CCL-61) grown to 80% confluency in
24-well plates were used for toxicity assays. Toxin-treated cells
were solubilized in 0.25 mL ice-cold HCl:EtOH (1:100) for
15 min at 4uC. Cell extracts were transferred to microcentrifuge
tubes and allowed to air dry. The dried extracts were reconstituted
in assay buffer, and cAMP levels were quantified using a
commercial kit (GE Healthcare, Piscataway, NJ). The basal level
of cAMP from unintoxicated cells was background subtracted
from the experimental values before presenting the data as
percentages of the maximal cAMP response for the experiment.

One week old pigs were anesthetized, and 3–4 loops per
condition were prepared. Each ligated segment was approximately
6 cm in length, with intervening 3 cm loops between the
experimental loops. A 1 mL volume of phosphate-buffered saline
(PBS) lacking or containing the stated extracts and/or toxins was
injected into the loops. At 8 h post-injection, the pigs were
euthanized, and each excised loop was measured for length and
fluid accumulation. The ratio of fluid accumulation to segment
length was calculated as a measure of toxin activity.

Assay for CTB Binding to the Cell Surface
CHO cells grown to 75% confluency in 96-well clear-bottom
black-walled plates (Greiner Bio-One, Monroe, North Carolina)

PLOS ONE | www.plosone.org
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Figure 5. Grape seed extract does not prevent toxin transport
to the ER. HeLa cells were incubated with CT for 30 min at 4uC.
Unbound toxin was removed, and the cells were warmed to 37uC.
Grape seed extract was only added to the cells 15, 30, or 60 min after
warming to 37uC. As additional controls, cells were untreated after
warming (Un) or were exposed to BfA at the time of warming (BfA). Cell
extracts generated after the 4uC pulse labeling (P) or after a total of 2 h
at 37uC were separated into membrane and cytosolic fractions. The
membrane fractions were resolved by non-reducing SDS-PAGE before
Western blot analysis with an anti-CTA1 antibody. Reduction of the
CTA1/CTA2 disulfide bond is indicative of toxin transport to the ER.
doi:10.1371/journal.pone.0073390.g005

Figure 4. Grape extracts confer protection against CT after
endocytosis of the toxin. CHO cells were incubated with CT for
30 min at 4uC. Unbound toxin was removed, and the cells were warmed
to 37uC. Grape seed extract, grape pomace extract, or BfA was added to
the cells at the time of warming to 37uC (0 min post-toxin incubation)
and 15, 30, or 60 min after warming to 37uC. cAMP levels were
determined 2 h after the initial warming to 37uC. The maximal cAMP
response was obtained from toxin-treated cells incubated in the
absence of extract or BfA. The averages 6 standard deviations of 3
independent experiments with triplicate samples are shown. At all time
intervals, the differences between untreated cells and extract- or BfAtreated cells were statistically significant (1-way ANOVA, p,0.01).
doi:10.1371/journal.pone.0073390.g004

Assay for Holotoxin Disassembly
CT was appended to a GM1-coated SPR sensor slide as
previously described [18]. PDI (0.1 mM) was then perfused over
the CT-coated sensor in PBS containing 0.05% Tween 20, 1 mM
GSH, and either grape seed or grape pomace extract. After
stabilization of the SPR signal, PDI was removed from the
perfusion buffer and replaced with sequential additions of antiCTA1 (1:5,000 dilution) and anti-KDEL (1:10,000 dilution)
antibodies.

Assay for Toxin Transport to the ER

were incubated with 1 mg/mL of FITC-CTB at 4uC under the
stated conditions. FITC-CTB was removed from the medium, and
the cells were washed with PBS before measurement with a
Synergy 2 plate reader (BioTek, Winooski, VT) using 485/20 nm
excitation and 528/20 nm emission wavelength filter cubes. The
fluorescent signal from CHO cells that had not been exposed to
FITC-CTB was background subtracted from experimental values
before presenting the data as percentages of the maximum
fluorescent signal for the experiment.

As previously described [18], HeLa cells (ATCC #CCL-2)
grown to 80% confluency in 6-well plates were treated with
100 ng/mL of GM1 for 1 h at 37uC. The cells were washed and
exposed to 1 mg/mL CT for 30 min at 4uC. This temperature
allows toxin binding to the plasma membrane but blocks
endocytosis of the surface-bound toxin. The cells were then
washed and incubated in toxin-free medium at 37uC, a
temperature that permits toxin endocytosis and intracellular
transport. Extracts were only added 15, 30, or 60 minutes after
warming to 37uC. With this protocol, the extracts would not block
toxin binding to the plasma membrane because they were only
added to the medium after endocytosis of the surface-bound toxin
had already occurred. After a total of 2 h at 37uC, cells were lifted
from the plates with 0.5 mM ethylenediaminetetraacetic acid in
PBS pH 7.4. Cell pellets obtained after low speed centrifugation
were resuspended in 0.1 mL HCN buffer (50 mM Hepes pH 7.5,
150 mM NaCl, 2 mM CaCl2, 10 mM N-ethylmaleimide, and a
protease inhibitor cocktail) containing 0.04% digitonin. After
10 min at 4uC, the semi-permeabilized cell extract was partitioned
into membrane and cytosolic fractions by centrifugation. The
membrane pellet was resuspended in 120 mL of 16sample buffer,
and a 25 mL sample was resolved by non-reducing sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) with a
15% polyacrylamide gel. Western blot analysis with a primary
rabbit anti-CTA1 antibody at 1:20,000 dilution and a secondary
horseradish peroxidase-conjugated goat anti-rabbit IgG antibody
at 1:20,000 dilution was used to detect the reduced and disulfidelinked forms of CTA1. HeLa cells were used for this assay rather
than CHO cells because, in our experience, the quantity of CTA1
which reaches the ER of CHO cells is often below the threshold of
Western blot detection. An overnight toxicity assay confirmed that

Use of Large Unilamellar Vesicles (LUVs) for SPR Studies
LUVs prepared as previously described [35] were formulated to
mimic the composition of the lipid raft binding site for CT: 5%
GM1, 30% cholesterol, 40% 1-Palmitoyl-2-Linoleoyl-sn-Glycero3-Phosphoethanolamine, 15% 1-Palmitoyl-2-Linoleoyl-sn-Glycero-3-Phospho-L-Serine, and 10% 1-Palmitoyl-2-Linoeoyl-snGlycero-3-Phosphocholine. Control LUVs lacking GM1 increased
the amount of 1-Palmitoyl-2-Linoleoyl-sn-Glycero-3-Phosphoethanolamine to 45%. To append the LUVs on an SPR sensor, a
Reichert self-assembled monolayer slide was activated with EDC/
NHS as previously described [36]. 25 mg of phytosphingosine
dissolved in 2.5 mL dimethyl sulfoxide was mixed with 2.5 mL of
40 mM sodium acetate (pH 5.2) and perfused over the activated
slide for 45 min at a flow rate of 41 mL/min. Unbound tethers left
on the slide were then inactivated with a 5 min perfusion of 1 M
ethanolamine (pH 8.5). A 1.6 mM concentration of LUVs was
then perfused over the slide for 5 min at a flow rate of 41 mL/min.
A subsequent 10 min perfusion with PBS containing 0.05%
Tween 20 was used to establish a stable baseline before perfusion
of CT over the LUV-coated sensor.

PLOS ONE | www.plosone.org
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Figure 6. Grape seed extract does not prevent PDI-mediated disassembly of the CT holotoxin. Reduced PDI and grape seed extract were
perfused over an SPR sensor coated with the CT holotoxin. The PDI- and extract-containing perfusion buffer was replaced with a buffer containing an
anti-CTA1 antibody (first arrowhead), which in turn was replaced with a buffer containing an anti-KDEL antibody (second arrowhead). At the
beginning of the experiment, the signal corresponding to the mass of the intact CT holotoxin was set at a baseline RIU value of zero (dotted line).
doi:10.1371/journal.pone.0073390.g006

bond, nor did they prevent disulfide reduction by b-mercaptoethanol. Aliquots from each master mix, corresponding to 1 mg toxin
samples, were incubated at 4uC, 25uC, 33uC, 37uC, or 41uC for
1 h and were then placed on ice. Thermolysin (prepared as a
106stock in 50 mM CaCl2 and 100 mM HEPES, pH 8.0) was
then added to a final concentration of 0.04 mg/mL for a 1 h
incubation at 4uC. The samples were resolved by SDS-PAGE
(15% polyacrylamide gels) and visualized with Coomassie staining.
Since all protease treatments were conducted at 4uC, differential
degradation of the toxin samples could not be attributed to
temperature-dependent protease activity. Instead, differences were
due to the temperature-induced alterations of CTA1 structure
which occurred prior to the 4uC protease treatment [17].

either grape extract could inhibit CT activity against HeLa cells
(data not shown).

CTA1 Translocation and Secretion Assays
HeLa cells exposed to GM1 and CT were processed as
described above for the toxin transport assay, except (i) media
samples were collected before lifting the cells from the plates; (ii)
the cell pellet was resuspended in 1 mL HCN/digitonin buffer;
and (iii) the cytosolic fraction was collected and diluted to a final
volume of 1 mL in HCN buffer. Media samples, cytosolic
fractions, and CTA standards were perfused over an SPR sensor
coated with an anti-CTA1 antibody as previously described [18].
As with the assay for toxin transport to the ER, this protocol has
been optimized for HeLa cells rather than the CHO cells which
produce weaker signals for both ER-localized and cytosolic CTA1
[16,18,36].

ADP-ribosylation Assay
Diethylamino(benzylidine-amino)guanidine (DEA-BAG), a substrate for the ADP-ribosyltransferase activity of CTA1 [37], was
synthesized by heating 500 mL of 0.11 M aminoguanidine
bicarbonate (Sigma-Aldrich) pH 6.5 to 60uC after filtration
removed insoluble solids. 4-Diethylaminobenzaldehyde (Acros
Organics) was added in 200 proof ethanol to make a 1:1 molar
ratio with aminoguanidine bicarbonate, and the solution was
stirred at room temperature for 16 h. The DEA-BAG precipitate
was harvested by filtration. The remaining solution was then
evaporated and cooled to promote further precipitate formation.

Protease Sensitivity Assay
A master mix of the purified CTA1/CTA2 heterodimer was
placed in 20 mM sodium phosphate buffer pH 7.4 containing
10 mM b-mercaptoethanol. Parallel master mixes were prepared
in the presence of either grape seed or grape pomace extract.
Control experiments using non-reducing SDS-PAGE established
that the grape extracts did not reduce the CTA1/CTA2 disulfide

PLOS ONE | www.plosone.org
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Figure 7. Grape extracts strip CT from lipid bilayers. At time point 0, CT was perfused over a SPR sensor coated with GM1-containing LUVs.
Grape seed or grape pomace extract was added to the perfusion buffer at 200 sec in the continued presence of CT. One of two representative
experiments is shown.
doi:10.1371/journal.pone.0073390.g007

of purified phenolic compounds (Table 1) to toxin-treated CHO
cells (Fig. 1C). This cocktail conferred substantial resistance to CT,
which suggested a phenolic compound(s) was at least partially
responsible for the extract-induced inhibition of CT activity
against cultured cells. Neither of the grape extracts nor the
phenolic cocktail inhibited cAMP production in cells treated with
forskolin, an agonist of adenylate cyclase (Fig. 1D).
The grape extracts acted as inhibitors in an intestinal model of
CT and LT intoxication as well (Fig. 2). For both CT (Fig. 2A) and
LT (Fig. 2B), the toxin-induced fluid accumulation was completely
negated by co-injection with either grape extract. Statistically
significant differences between toxin-treated and toxin/extracttreated loops were detected for both CT and LT. Thus, the
extracts could effectively block CT/LT intoxication of both
cultured cells and intestinal loops. Additional experiments were
performed in order to identify the molecular basis for extractinduced resistance to CT.

The collected DEA-BAG precipitate was lyophilized and stored at
280uC.
Dilutions of CTA1/CTA2 were placed in 200 mM Na/K
phosphate buffer pH 7.5 containing 20 mM DTT, 0.1 mg/mL
bovine serum albumin, 10 mM NAD, and 2 mM DEA-BAG. BioRad (Hercules, CA) AG-50W-X4 ion exchange resin was added to
the reaction mixture after 2 h at 25uC. DEA-BAG loses its ability
to bind this resin after ADP-ribosylation, so unmodified DEABAG was removed from the reaction mixture by pelleting the resin
in a microcentrifuge tube. The relative amount of ADPribosylated DEA-BAG remaining in the supernatant was determined by measuring the intrinsic fluorescence of DEA-BAG with a
Synergy 2 plate reader at 360 nm excitation and 460 emission
wavelengths.

Results
Grape Extracts Block Intoxication of Cultured Cells and
Intestinal Loops

Grape Extracts Block Toxin Interactions with GM1

Our previous work identified grape seed and grape pomace
extracts as potent inhibitors of ST [30]. To determine whether the
extracts could inhibit other toxins as well, we exposed CHO cells
to various concentrations of CT in the absence or presence of
grape extract. Cells exposed to either grape seed or grape pomace
extract exhibited high levels of resistance to CT after both shortterm (Fig. 1A) and long-term (Fig. 1B) toxin exposures. Extracttreated cells were also resistant to E. coli LT, another AB5-type
toxin that is highly related to CT [1,2]: an overnight incubation
with 100 ng/mL of LT and either grape extract generated no
more than 8% of the cAMP response obtained from cells
incubated with LT alone (n = 2). Grape extracts are highly
enriched in polyphenolic compounds with established anti-toxin
properties [38–42]. We therefore hypothesized that the phenolic
constituents of grape extract represent a source of anti-toxin
compounds. To test this hypothesis, we applied a defined cocktail

Plant compounds can affect intoxication through an inhibition
of toxin binding to the plasma membrane [31,43,44]. To
determine if the grape extracts blocked CT binding at the cell
surface, we incubated CHO cells at 4uC with a FITC-conjugated
CTB pentamer in the absence or presence of grape extract (Fig. 3).
Toxin binding to the cell surface occurs at 4uC, but endocytosis of
the bound toxin is blocked. Thus, our assay specifically monitored
host-toxin interactions at the cell surface. A preliminary control
experiment ensured that the extracts did not directly quench the
fluorescent signal from FITC-CTB (data not shown). Any
reduction in the fluorescent signal obtained from extract-treated
cells would therefore reflect an extract-induced inhibition of toxin
binding to the cell surface. As shown in Figure 3A, both extracts
blocked FITC-CTB binding to the cell surface when co-incubated
with the toxin. Pre-treatment of the cell surface with grape extract,
followed by FITC-CTB incubation in the absence of extract, did
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binding to the cell surface was one mechanism involved with
extract-induced toxin resistance.

Grape Extracts Inhibit Intoxication after Toxin
Endocytosis
Additional cell-based experiments demonstrated that the
extracts inhibited host-toxin interactions downstream of the toxin
binding event as well (Fig. 4). CHO cells were exposed to CT at
4uC and then warmed to 37uC, a temperature that permits
endocytosis of the surface-bound toxin. Extracts were only added
15, 30, or 60 minutes after warming to 37uC. Although delayed
exposure to the extract would allow toxin binding and endocytosis
to occur, we still detected extract-induced blocks of intoxication. In
fact, application of the extracts 30 min after toxin exposure was as
effective at blocking intoxication as a co-incubation of the toxin
and extract throughout the experiment. A strong inhibitory effect
on intoxication was also documented when the extracts were
applied 60 minutes after the initial toxin exposure. These results
demonstrated that the grape extracts can disrupt intoxication even
after toxin internalization into the host cell. BfA also inhibited CT
activity against cultured cells but was not as effective as the extracts
when applied 30 or 60 min after toxin exposure. The continued
efficacy of the extracts at later post-exposure time points suggested
that the extracts disrupted host-toxin interactions downstream of
the BfA-sensitive trafficking event.

Grape Extracts do not Inhibit Toxin Transport to the ER or
Holotoxin Disassembly
To determine if the grape extracts blocked CT trafficking to the
ER, we monitored the redox status of CTA1. Reduction of the
CTA1/CTA2 disulfide bond occurs in the ER [11,12], so the
appearance of reduced CTA1 can be used as an indicator of toxin
transport to the ER [15,18]. HeLa cells were incubated with 1 mg/
mL of CT at 4uC for 30 min. Unbound toxin was removed, and
the cells were then placed at 37uC to permit endocytosis of the
surface-bound toxin. Grape extract was added 15, 30, or 60
minutes after warming to 37uC. With this protocol, the extracts
would not block toxin binding to the plasma membrane because
they were only added to the medium after endocytosis of the
surface-bound toxin had already occurred. CTA1 in the membrane fraction of digitonin-permeabilized cells was collected after a
total of 2 hours at 37uC, resolved by non-reducing SDS-PAGE,
and visualized with Western blot analysis. As shown in Figure 5, a
pool of reduced CTA1 could be detected in the untreated control
cells but not in BfA-treated cells. The latter result demonstrated
that trafficking to the ER was a prerequisite for reduction of the
CTA1/CTA2 disulfide bond. A pool of reduced CTA1 could also
be detected in cells treated with grape seed extract at 15, 30, or 60
minutes after warming to 37uC. An identical result was obtained
from cells treated with grape pomace extract (data not shown).
These observations indicated that the extracts did not inhibit toxin
trafficking to the ER, which was somewhat surprising as at least
one plant compound has demonstrated inhibitory effects on
retrograde toxin transport [45].
CTA1 remains associated with the holotoxin through noncovalent interactions after reduction of the CTA1/CTA2 disulfide
bond in the ER [46]. Separation of CTA1 from CTA2/CTB5,
which is a prerequisite for CTA1 translocation to the cytosol,
involves the action of PDI [13,14]. To determine whether the
grape extracts disrupt PDI-mediated disassembly of the CT
holotoxin, we reconstituted this event on a SPR sensor slide (Fig. 6).
The CT holotoxin was appended to a GM1-coated sensor slide,
and a baseline measurement which reflected the mass of the intact

Figure 8. Grape extracts prevent the temperature-induced
unfolding of CTA1. (A) A purified CTA1/CTA2 heterodimer was
placed in 20 mM sodium phosphate buffer (pH 7.4) containing 10 mM
b-mercaptoethanol. Aliquots (1 mg) of the toxin were either left
untreated, treated with grape seed extract, or treated with grape
pomace extract as indicated. All samples were incubated at the
indicated temperatures for 1 h. The toxins were then shifted to 4uC and
exposed to the thermolysin protease for 1 h. Samples were resolved by
SDS-PAGE and Coomassie staining, which does not visualize the 5 kDa
CTA2 subunit. (B) Purified a-casein was placed in 20 mM sodium
phosphate buffer (pH 7.4) containing 10 mM b-mercaptoethanol.
Aliquots (5 mg) of the protein were incubated from 1 h at 4uC in the
absence or presence of thermolysin before visualization by SDS-PAGE
and Coomassie staining. Samples exposed to thermolysin were
untreated or co-incubated with either grape seed or grape pomace
extract as indicated.
doi:10.1371/journal.pone.0073390.g008

not substantially inhibit toxin binding (Fig. 3B). This indicated that
the extracts bound directly to the toxin rather than to the host cell.
Surprisingly, the extracts could even strip pre-bound toxin from
the plasma membrane: a greatly attenuated FITC-CTB signal was
obtained when cells were exposed to FITC-CTB for 30 min at
4uC before the addition of grape extract for another 30 min at 4uC
(Fig. 3C). In our final variation on the toxin binding assay, extract
and FITC-CTB were mixed in the absence of cells. The mixture
was subjected to overnight dialysis with a 3500 MWCO filter, and
the retained FITC-CTB was then applied to cultured cells. This
procedure recorded a substantial inhibition of toxin binding for
the grape seed extract but not for the grape pomace extract
(Fig. 3D). Thus, at least one compound in the seed extract
exhibited a high affinity interaction with FITC-CTB that allowed
it to be retained after overnight dialysis. In contrast, anti-toxin
agents in the pomace extract exhibited lower affinity interactions
with FITC-CTB and were consequently removed by dialysis.
Collectively, these results demonstrated that an inhibition of toxin
PLOS ONE | www.plosone.org
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Figure 9. Grape extracts prevent CTA1 translocation to the cytosol. HeLa cells were incubated with CT for 30 min at 4uC. Unbound toxin was
removed, and the cells were warmed to 37uC. Grape pomace (A) or grape seed (B) extract was added to the cells 15, 30, or 60 min after warming to
37uC. Cell extracts generated after a total of 2 h at 37uC were separated into membrane and cytosolic fractions, and the cytosolic fractions were
perfused over an SPR sensor coated with an anti-CTA1 antibody. The cytosolic fraction from unintoxicated cells was used as a negative control, and
CTA standards were used as positive controls. All samples were perfused over the same SPR sensor; the data is presented in two panels for clarity.
One of two representative experiments is shown.
doi:10.1371/journal.pone.0073390.g009

perfusions of anti-CTA1 and anti-KDEL antibodies over the
sensor: a positive signal was obtained with the anti-KDEL
antibody (which recognizes the C-terminus of CTA2) but not
the anti-CTA1 antibody, demonstrating that PDI had displaced
CTA1 from the sensor-bound CTA2/CTB5 complex. This
phenomenon has been documented by SPR in previous publications as well [13,16,18]. Here, we used the assay to demonstrate
that grape seed extract does not inhibit PDI-mediated disassembly
of the CT holotoxin. Additional experiments confirmed that PDImediated holotoxin disassembly could also occur in the presence of
grape pomace extract (data not shown).

toxin was recorded. PDI and grape seed extract were then
perfused over the CT sensor slide in a reducing buffer. Binding of
PDI to the holotoxin increased the mass on the surface of the
sensor, and this generated a corresponding increase in the
refractive index unit (RIU; the angle of light reflected by the
slide). However, the elevated RIU signal quickly dropped below
the baseline value corresponding to the mass of the bound
holotoxin. The drop in RIU, which occurred despite the
continued presence of PDI in the perfusion buffer, indicated that
both PDI and a portion of the CT holotoxin had been removed
from the plate. We confirmed this interpretation with sequential
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Figure 10. Grape extracts do not prevent the secretion of free CTA1. HeLa cells were incubated with CT for 30 min at 4uC. Unbound toxin
was removed, and the cells were warmed to 37uC. BfA was added immediately after warming, and grape pomace or grape seed extract was added to
the cells 15 min after warming to 37uC. Media samples collected after a total of 2 h at 37uC were perfused over an SPR sensor coated with an antiCTA1 antibody. The extracellular medium from unintoxicated cells was used as a negative control, and CTA standards were used as positive controls.
One of two representative experiments is shown.
doi:10.1371/journal.pone.0073390.g010

were due to the use of CT (SPR) vs. FITC-CTB (cell culture). We
found that neither grape extract could remove pre-bound CT,
CTB pentamer, or FITC-CTB from GM1-coated SPR sensor
slides (data not shown). Thus, the differential effects did not arise
from use of a CTB pentamer or a FITC-conjugated CTB
pentamer. The fluid, complex nature of the plasma membrane (as

Grape extracts could strip pre-bound FITC-CTB from the
surface of cultured CHO cells (Fig. 3), but they did not strip CT
from the GM1-coated SPR sensor slide (Fig. 6). The CT holotoxin
reportedly has a higher avidity for GM1 than the CTB pentamer
has for GM1 [47], so we performed additional experiments to
determine if the differential effects observed in SPR vs. cell culture

Figure 11. Grape extracts inhibit the ADP-ribosyltransferase activity of CTA1. (A) Dilutions of CTA1 mixed with DEA-BAG in the presence or
absence of grape extract were placed at 25uC for 2 h. The ADP-ribosylation of DEA-BAG was then assessed by fluorometry; increasing fluorescent
units correspond to increasing levels of substrate modification. Data are presented as the averages 6 ranges of two replicate samples per condition.
One of two representative experiments is shown. (B) DEA-BAG was placed in buffer lacking or containing either grape seed or grape pomace extract.
The intrinsic fluorescence of DEA-BAG and extract-treated DEA-BAG was then assessed by fluorometry. Data are presented as percentages of the
value obtained from untreated DEA-BAG, which was used at a concentration that did not saturate signal detection. The averages 6 standard
deviations of 3 independent experiments with triplicate samples are shown.
doi:10.1371/journal.pone.0073390.g011
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extract after 15 minutes of intoxication, although some cytosolic
CTA1 was present when grape seed extract was added 30 or 60
minutes after the initial toxin exposure (Fig. 9B). These results
correlated well with the toxicity data of Figure 4 which suggested
the seed extract was slightly less protective than the pomace
extract when applied at 30 or 60 minutes post-intoxication. The
data were also consistent with the observed extract-induced
inhibition of CTA1 unfolding (Figure 8), which would in turn
prevent CTA1 translocation to the cytosol [15,16,18].

opposed to an immobilized GM1 monolayer on a SPR sensor)
apparently contributes to the ability of grape extract to strip prebound toxin from the host cell surface. Different results for in vitro
vs. cell-based assays have also been noted for the interaction
between ST and its glycosphingolipid Gb3 receptor; these
differences have likewise been attributed to the fluidity and
complexity of the plasma membrane [48]. To further examine this
possibility, we appended GM1-containing LUVs to a SPR sensor
slide. The LUVs were formulated to mimic the composition of the
lipid raft binding site for CT (see Materials and Methods).
Perfusion of CT over the LUV-coated sensor resulted in toxin
retention on the slide. Subsequent addition of either grape extract
to the perfusion buffer resulted in the displacement of CT from the
sensor slide, although the toxin was removed more efficiently by
grape seed extract than grape pomace extract (Fig. 7). After
removal of either extract from the perfusion buffer, the sensor was
able to re-capture a fresh sample of CT that was added to the
perfusion buffer (data not shown). This confirmed that the LUVs
were retained on the extract-treated sensor. LUVs lacking GM1
were unable to capture CT at the preliminary stage of the
experiment, thus demonstrating the specificity of CT binding to
GM1-containing membranes (data not shown). Collectively, our
data indicated grape extracts can strip GM1-bound CT from fluid
lipid bilayers but not from an immobilized GM1 monolayer.

Grape Extracts do not Block Anterograde Vesicular
Transport of the Dissociated CTA1 Subunit
When CTA1 is released from its holotoxin in the ER, a portion
of free CTA1 enters the secretory pathway and is released into the
extracellular medium [16]. To detect the secreted pool of free
CTA1 from untreated and extract-treated cells, we collected
media samples from cells used for the translocation assay of
Figure 9 as well as from BfA-treated cells. These samples were
perfused over an SPR sensor coated with an anti-CTA1 antibody.
No signal was obtained from the medium of unintoxicated control
cells or from the medium of intoxicated, BfA-treated cells (Fig. 10).
Both anterograde and retrograde vesicular transport pathways are
disrupted by BfA, which consequently prevents the secretion of
free CTA1 [16]. Media samples from CT-treated cells incubated
in either the absence or presence of grape extract produced
roughly equivalent SPR signals, indicating that a post-toxin
exposure to grape extract did not substantially inhibit secretion
of the dissociated CTA1 subunit. To ensure the extracellular pool
of toxin represented free CTA1 and not holotoxin-associated
CTA1, we used an anti-CTB antibody to immunodeplete the
CTB pentamer and CT holotoxin from parallel media samples
before their perfusion over the CTA1 sensor. This procedure did
not result in any loss of signal (data not shown). Such a result
demonstrated that, consistent with previous observations [16], the
extracellular pool of toxin was free CTA1 and not CT holotoxin.
Thus, the grape extracts did not block (i) retrograde CT transport
to the ER (see also Fig. 5); (ii) CTA1 dissociation from CTA2/
CTB5 (see also Fig. 6); or (iii) anterograde secretory transport of
free CTA1 from the ER to the extracellular medium.

Grape Extracts Inhibit the Thermal Unfolding of CTA1
An in vitro assay demonstrated that the extracts could alter the
structural properties of CTA1. After dissociation from the
holotoxin in the ER, the isolated CTA1 subunit unfolds
spontaneously at physiological temperature [17]. This unfolding
event places CTA1 in a protease-sensitive conformation and
triggers its ERAD-mediated export to the cytosol [16,17]. As
shown in Figure 8A, both grape extracts blocked the temperatureinduced shift of CTA1 to a protease-sensitive (i.e., unfolded)
conformation. Proteolysis of a-casein, a protein with an open and
protease-sensitive conformation [49], was not inhibited by the
extracts (Fig. 8B). This demonstrated that the extract-induced
block of CTA1 degradation was not due to an inhibition of the
protease itself. When combined with the results of Figure 3, the
protease sensitivity assay demonstrated that both the catalytic and
cell-binding components of CT are affected by the extracts. We
have previously shown that the thermal stabilization of CTA1 will
block toxin export to the cytosol and productive intoxication
[15,16,18]. Thus, extract-induced resistance to CT may also
involve a disruption of toxin translocation to the cytosol.

Grape Extracts Inhibit the Enzymatic Activity of CTA1
Plant extracts and phenolic compounds have predicted [50] or
demonstrated [32,33,45] inhibitory effects on the ADP-ribosyltransferase activity of CTA1. An in vitro assay was accordingly
used to monitor the enzymatic function of CTA1 in the presence
of grape seed or grape pomace extract. As shown in Figure 11A,
both extracts affected CTA1 activity: the dose-dependent modification of DEA-BAG, a synthetic substrate for the ADPribosylation activity of CTA1, was inhibited but not completely
blocked in the presence of either grape extract. Control
experiments demonstrated that neither grape extract directly
quenched the intrinsic fluorescence of the DEA-BAG substrate
which was used to monitor toxin activity (Fig. 11B, see also
Materials and Methods).

Grape Extracts Inhibit CTA1 Translocation to the Cytosol
To directly examine the potential extract-induced disruption of
toxin translocation, we performed the cellular pulse-chase protocol
previously utilized to monitor the redox status of cell-associated
CTA1. For this assay, the cytosolic fraction of digitoninpermeabilized cells was collected and perfused over an SPR
sensor coated with an anti-CTA1 antibody (Fig. 9). Capture of
cytosolic CTA1 by the anti-CTA1 antibody would increase the
mass on the sensor slide, and this would subsequently be detected
as an increase in the RIU. Whereas slightly more than 0.1 ng/mL
of CTA1 was detected in the cytosol of untreated cells, only
minimal levels of cytosolic toxin were detected from cells treated
with grape pomace extract 15, 30, or 60 minutes after the initial
toxin exposure (Fig. 9A). The signal generated from cells treated
with grape pomace extract was only slightly greater than the
baseline signal from the antibody-coated sensor (0 RIU) and the
signal obtained from the cytosol of unintoxicated cells. No signal
was obtained from the cytosol of cells treated with grape seed
PLOS ONE | www.plosone.org

Discussion
The grape seed and grape pomace extracts used in this study are
sold as nutritional supplements under the names MegaNatural
Gold and MegaNatural GSKE, respectfully. Both extracts are
Generally Recognized as Safe by the United States Food and Drug
Administration. Studies with human volunteers have shown that
the extracts retain bioactivity after oral ingestion of up to 600 mg/
day of extract [51,52]. In this study, we demonstrated the potential
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utility of grape extract as a therapeutic to prevent and possibly
treat cholera.
Like other plant extracts [31,43], the grape seed and grape
pomace extracts blocked CT binding to the cell surface. This effect
apparently involved an interaction with the toxin rather than the
host, as pretreatment of the host cell with grape extract did not
prevent the subsequent binding of FITC-CTB in the absence of
extract. Furthermore, at least one compound in the grape seed
extract exhibited a high affinity interaction with CTB that allowed
it to be retained with the toxin (and to inhibit toxin binding) after
an overnight dialysis. A post-dialysis block of FITC-CTB binding
to the target cell was not observed when the toxin was treated with
grape pomace extract, thus demonstrating that the two grape
extracts contain different anti-toxin components or different
effective concentrations of the same anti-toxin component.
We also noted that both extracts could strip pre-bound toxin
from the plasma membrane. To the best of our knowledge, this is
the first demonstration of CT removal from the cell surface by a
non-toxic plant extract. The mechanism by which CTB is
removed from the cell surface remains to be determined and is
of high interest, but the responsible compound(s) will need to be
isolated before the molecular details of this event can be
established. Still, the observations reported here suggest grape
extracts could provide a post-exposure medicinal benefit by
stripping bound CT from the surface of target enterocytes.
Our intoxication assays also indicated the extracts could
function as effective inhibitors when applied after toxin exposure.
Extract-treated cells were highly resistant to CT, even when the
extracts were applied an hour after toxin challenge. This
demonstrated that the extracts can disrupt CT intoxication
downstream of toxin binding and endocytosis. Our work identified
a number of these downstream events. In vitro, both extracts
blocked the temperature-induced shift of CTA1 to a disordered,
protease-sensitive conformation. Previous work has shown that
thermal disordering of the dissociated CTA1 polypeptide is a
prerequisite for its translocation to the cytosol, and our in vivo
translocation assay indeed detected an inhibition of CTA1
translocation in extract-treated cells. The ADP-ribosyltransferase
activity of CTA1 was also inhibited by the grape extracts.
Our collective data thus demonstrated that multiple steps of the
CT intoxication process are inhibited by grape extract. Events
involving both the A1 subunit and the B pentamer were affected.
This may explain, in part, the potent anti-toxin properties of the
extracts: productive intoxication of extract-treated cells would
require CT to overcome disruptions of (i) CTB binding to the cell
surface; (ii) unfolding and translocation of the ER-localized CTA1
subunit; and (iii) CTA1 enzymatic activity. Each of these events
involves CT rather than the host cell, which is consistent with the
non-toxic nature of the extracts [30] and the lack of extractinduced alterations to adenylate cyclase signaling, redox status,
protease function, and anterograde/retrograde vesicle trafficking.
The grape extracts affected many, but not all, steps of the CT
intoxication process. Retrograde transport of the toxin to the ER
was not blocked in extract-treated cells. Likewise, PDI could still
dislodge CTA1 from CTA2/CTB5 in the presence of grape
extract. A portion of the dissociated CTA1 subunit moves from the
ER to the Golgi apparatus and is released into the medium; this
event was not substantially affected by the grape extracts. Previous
studies have suggested the polyphenolic constituents of plant

extracts can induce non-specific protein aggregation that may be
at least partially responsible for toxin resistance [31,45,53].
However, grape extracts appear to generate specific inhibitory
effects because they only disrupt a subset of intoxication events. It
is possible that the concentrations of individual polyphenolic
compounds in our grape extracts (used at 100 mg/mL concentrations for all experiments) were too low to induce non-specific
protein aggregation. For example, peptides are only precipitated
by the plant polyphenol epigallocatechin gallate when it is present
at concentrations greater than ,4.5 mg/mL [53]. The tannininduced precipitation of Staphylococcal a-toxin likewise required a
polyphenol concentration of 400 mg/mL [54], while the partial
precipitation of CT by resveratrol required a polyphenol
concentration of 46 mg/mL [45]. The lack of grape extractinduced protein precipitation is also consistent with the fact that
our extracts are not toxic when applied to cells at concentrations
up to 500 mg/mL [30].
Grape seed and grape pomace extracts have known chemical
compositions: they are highly enriched in polyphenolic compounds which exhibit medicinal properties for heart disease and
other disorders [51,52,55,56]. Polyphenolic compounds from
other plant extracts have demonstrated anti-toxin activities against
CT, Helicobacter pylori VacA, Staphylococcal a-toxin, and anthrax
lethal factor [31–33,42,44,45,54,57,58]. Furthermore, computational analysis has predicted an inhibition of CTA1 catalytic
activity by the catechin family of polyphenolic compounds [50].
These observations strongly suggest a polyphenolic compound(s) in
the grape extract is responsible for the multiple disruptions of hosttoxin interactions that result in the inhibition of CT/LT activity
against cultured cells and intestinal loops. In support of this
hypothesis, we found that cells treated with a defined cocktail of
purified phenolic compounds exhibited substantial resistance to
CT (Fig. 1C). Future screens of individual polyphenolic compounds and cocktails of defined polyphenolic composition will
identify the specific anti-toxin components of the grape extracts.
The post-dialysis retention of an anti-toxin compound(s) with the
CTB pentamer (Fig. 3D) should also facilitate inhibitor identification.
In summary, two over-the-counter nutritional supplements
strongly inhibit CT/LT activity against cultured cells and
intestinal loops. Both of these grape extracts target a subset of
toxin-specific events that are required for productive intoxication.
In vivo intoxication is likely an asynchronous process, with
individual enterocytes exhibiting cytopathic effects at different
stages of infection. In theory, grape extracts could therefore
represent a new anti-toxin therapeutic with medicinal value as a
prophylactic or even after pathogen/toxin exposure.
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